233 related articles for article (PubMed ID: 32085454)
1. Cas3 Protein-A Review of a Multi-Tasking Machine.
He L; St John James M; Radovcic M; Ivancic-Bace I; Bolt EL
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085454
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
3. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
[TBL] [Abstract][Full Text] [Related]
4. Fitting CRISPR-associated Cas3 into the helicase family tree.
Jackson RN; Lavin M; Carter J; Wiedenheft B
Curr Opin Struct Biol; 2014 Feb; 24():106-14. PubMed ID: 24480304
[TBL] [Abstract][Full Text] [Related]
5. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
[TBL] [Abstract][Full Text] [Related]
6. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
Radovčić M; Čulo A; Ivančić-Baće I
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
[TBL] [Abstract][Full Text] [Related]
7. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.
Sinkunas T; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
EMBO J; 2011 Apr; 30(7):1335-42. PubMed ID: 21343909
[TBL] [Abstract][Full Text] [Related]
8. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
Loeff L; Brouns SJJ; Joo C
Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
[TBL] [Abstract][Full Text] [Related]
9. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.
Beloglazova N; Petit P; Flick R; Brown G; Savchenko A; Yakunin AF
EMBO J; 2011 Oct; 30(22):4616-27. PubMed ID: 22009198
[TBL] [Abstract][Full Text] [Related]
10. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
Majsec K; Bolt EL; Ivančić-Baće I
BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
[TBL] [Abstract][Full Text] [Related]
11. Helicase dissociation and annealing of RNA-DNA hybrids by Escherichia coli Cas3 protein.
Howard JA; Delmas S; Ivančić-Baće I; Bolt EL
Biochem J; 2011 Oct; 439(1):85-95. PubMed ID: 21699496
[TBL] [Abstract][Full Text] [Related]
12. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
[TBL] [Abstract][Full Text] [Related]
13. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3).
Mulepati S; Bailey S
J Biol Chem; 2011 Sep; 286(36):31896-903. PubMed ID: 21775431
[TBL] [Abstract][Full Text] [Related]
14. Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex.
Nimkar S; Anand B
Nucleic Acids Res; 2020 Mar; 48(5):2486-2501. PubMed ID: 31980818
[TBL] [Abstract][Full Text] [Related]
15. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
[TBL] [Abstract][Full Text] [Related]
16. Cas3 nuclease-helicase activity assays.
Sinkunas T; Gasiunas G; Siksnys V
Methods Mol Biol; 2015; 1311():277-91. PubMed ID: 25981480
[TBL] [Abstract][Full Text] [Related]
17. Repurposing the atypical type I-G CRISPR system for bacterial genome engineering.
Shangguan Q; White MF
Microbiology (Reading); 2023 Aug; 169(8):. PubMed ID: 37526970
[TBL] [Abstract][Full Text] [Related]
18. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution and biochemical characterization of the RNA-guided helicase-nuclease protein Cas3 from type I-A CRISPR-Cas system.
Hu C; Ke A
Methods Enzymol; 2022; 673():405-424. PubMed ID: 35965014
[TBL] [Abstract][Full Text] [Related]
20. Adaptation processes that build CRISPR immunity: creative destruction, updated.
Lau CH; Reeves R; Bolt EL
Essays Biochem; 2019 Jul; 63(2):227-235. PubMed ID: 31186288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
